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RESEARCH ARTICLE
EFFICACY OF THE KETOGENIC DIET AS A THERAPY FOR 
INTRACTABLE EPILEPSY IN CHILDREN
Abstract
Objective
To determine the role of ketogenic diet in the treatment of intractable 
epilepsy in children.
Materials & Methods
Sixty six consecutive children (1-16 years old) with intractable epilepsy 
whose seizure were not neurodegenerative nor febrile in origin were 
recruited. They  received the ketogenic diet and we evaluated its effect 
on seizure frequency for 3 months. All these children had more than five 
seizures per week despite adequate therapy with at least 3-4 anticonvulsant 
medications. Carbohydrates were initially limited to 10 gr/day and fats 
constituted 75% of the total energy requirement. Response to the diet 
was categorized as free of seizure, 99%-75%, 50%-75%, 25%-49% and 
lower than 25% reduction (resistant to therapy).
Results
Fifty five patients (84%) out of 66 children initiating the diet continued it 
after 1 week. After 3 months, 80% of the patients kept the diet. After one 
week, one month and 3 months, there was a more than 50% decrease 
in the frequency of the seizures in 40 (60%), 50 (75%) and 39 (59%) of 
the patients, respectively. Three patients (4.5%) were seizure-free after 
1 week, 12 (18%) were seizure-free after one month and 12 (18%) were 
seizure-free after three months and a significant relationship was found 
between seizure reduction and the type of epilepsy (p<0.017).
Conclusion
The ketogenic diet should be considered as an alternative therapy for 
children with intractable seizures. It is more effective than many of the 
new anticonvulsant medications and is well tolerated by children and 
their families.
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Introduction
Epilepsy is a commonly treatable neurological condition with a prevalence of ten 
to thirty per 1000 in general population (1). Diets have been attempted extensively 
to control epileptic seizures throughout the centuries. The first scientific assessment 
using dietary manipulation was reported by Guelpa (2). Subsequently, Geyelin 
confirmed the fact that seizures ceased on absolute fasting. However, neither of 
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these studies were randomized controlled trials (3). 
Wilder suggested that a diet high in fat and low in 
carbohydrate would be similar to fasting, attributing 
the anticonvulsant properties to the production of 
ketones (4). Numerous biochemical theories have been 
suggested for the possible role of the diet, including 
the anticonvulsant effect of ketone bodies (acetoacetate 
beta-hydroxybutyrate), ketone reduction of alanine 
efflux, charge of water and electrolyte imbalance (5) 
or changes occurring either in the nerve cell lipid 
membranes or the production of neurotransmitters (6).
The ketogenic diet (KD) is a high-fat, low-protein, 
low-carbohydrate diet used for treating medically 
refractory epilepsy for 86 years. The “classic” KD 
is based upon consumption of long-chain saturated 
triglycerides (LCTs) in a 3:1 or 4:1 ketogenic diet ratio 
of fats to carbohydrates + protein (by weight). A major 
proportion of the calorie (>75%) is derived from fat 
(7). It should be considered as the first-line therapy in 
glucose transporter type 1 and pyruvate dehydrogenase 
deficiency. It should also be considered early in the 
treatment of Dravet syndrome and myoclonic-astatic 
epilepsy (Doose syndrome) (8). This diet is rarely 
initiated because it is unpleasant and requires strict 
compliance (9). Clinical performance of KD has been 
different in various centers, but the diet almost always 
starts with fasting and then a steady increase in calories 
to reach a KD ratio of 3:1–4:1 (10).
This process happens in the inpatient setting after 
several days and it is necessary to monitor the levels 
of blood glucose, urine ketones, and several other 
metabolic variables very precisely. 
Some studies suggest that the KD activates several 
endogenous metabolic and genetic “programs” to 
stabilize and/or enhance cellular metabolism, and 
that these fundamental changes help counter neuronal 
dysfunction associated with seizure activity (7, 10).
Prior to the availability of anticonvulsant medications, 
the ketogenic diet was used for the treatment of 
epilepsy. However, in the last 10 to 30 years, many 
researchers have evaluated the efficacy of the ketogenic 
diet in cases with multiple seizure types who were 
refractory to multiple antiepileptic drugs (AEDs) (11). 
Most of the studies regarding KD are retrospective 
and not randomized or controlled; therefore, statistical 
interpretation and accurate assessment of these studies 
are difficult (12).
Materials & Methods
This study was a quasi-experimental survey with 
a sample volume of 66 children with refractory 
seizures who were visited at Mofid Hospital, Tehran, 
from October 2008 to June 2010 (32 months). Sixty 
six children with intractable seizures (resistant to 3-
4 antiepileptic drugs) were consecutively enrolled. 
Patients were included in the study if 1) Age range was 
1-16 years old 2) No neurodegenerative disorders and 
neoplasm of CNS were detected 3) The seizures were 
not due to febrile convulsions 4) The parents had at 
least primary school education. In the first meeting, our 
dietitian explained the ketogenic diet and the goals of 
the study in a comprehensible language to the family. 
Then, the parents signed informed consent forms and 
before starting the diet, parents were asked to register 
the frequency of their child’s seizures in a diary (number 
of seizures/day) for a period of one week. After the 
children were admitted, they received the standard 
ketogenic diet as follows:
According to the traditional ketogenic diet, the patients 
were initially hospitalized in the pediatric neurology 
ward, their complete nutritional history with 3-day 
food and fluid records were reviewed by the managing 
dietitian. Consequently, fasting and fluid restriction was 
undertaken until strong urinary ketosis was achieved 
(3+- 4+). The patients were then fed a single daily 
meal of a 3:1 ratio diet (the amount derived from fat 
compared with the amount derived from protein and 
carbohydrates). The diet gradually increased in amount 
until the total daily required calories were provided. 
High-fat foods provided one third of the total daily 
required calories on the first day, two thirds of the 
required calories on the second day and full required 
calories on the third day of treatment. All currently 
administered AEDs except for acetazolamide and 
zonisamide were continued, and all patients remained 
hospitalized until acceptable tolerance was established 
and the education of the caregivers regarding the diet 
was completed (usually 1 week).
In order to evaluate treatment efficacy, the 
medical records of all KD patients were reviewed 
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retrospectively by comparing daily seizure counts of 
the one-week baseline before starting KD with the 
first week after initiation of the diet from the seizure 
calendars. Data regarding diet tolerability, outbreak of 
strong urine ketosis of higher than 3+ (50-150 mg/dL), 
appearance of moderate dehydration determined as 
more than 5% decrease in body weight compared to the 
baseline and the related symptoms and complications 
was also gathered. Finally, the results of standard 
laboratory tests, including blood urea nitrogen (BUN), 
creatinine, electrolytes, liver enzymes, cholesterol, 
triglyceride, and uric acid levels were recorded. Tests 
were considered abnormal according to the Nelson 
Textbook of Pediatrics, 18th edition (2008).
When the caregiver understood the protocol, patients 
were discharged with the prescription of supplements 
including carbohydrate-free multi vitamins and 
calcium pills based on their weight. Urinary ketones 
were measured once weekly for three months. The 
patients’ families were contacted by telephone and 
the responder was almost always the mother. 
The parents were asked to rate the effect of the diet 
based on the frequency and intensity of the seizures 
by daily documentation of speech/communication, 
comprehention/understanding, self-care, social 
interaction such as interest in others, playing, attention 
span/alertness, activity level, sleeping, motor skills, 
endurance and behavior. At the initial follow-up one 
month later, the children were brought to the clinic 
and visited by a member of the research team (a child 
neurologist, a pediatric resident  or a managing dietitian) 
and the parents were asked about the frequency and 
intensity of the child’s seizures and tolerability of 
the diet. Blood sugar, blood urea nitrogen (BUN), 
creatinine, electrolytes, liver enzymes, cholesterol, 
triglyceride, serum lipoproteins, AED plasma levels, 
and randomized urine calcium and creatinine (Ca/
Cr ratio), for ruling out renal stones as one of the 
complications of ketogenic diet, were requested. The 
second follow-up visit was repeated three months after 
starting the diet. 
Variables
The variables included sex, age, parents’ education 
and occupation, type of seizure, presence of epileptic 
syndrome, kind of epilepsy, neurological delay, EEG 
and neuroimaging findings (MRI, CT, SPECT), ketone 
after 1 and 3 months, seizure frequency after 1 week, 
one month and 3 months, and antiepileptic drugs 
(AEDs) consumption. 
Data Collection
We collected our data by a questionnaire which was 
filled by the researcher and contained the above-
mentioned variables.
Data Analysis
Data analysis was performed by SPSS-17 statistical 
software and differences in seizure frequency and 
other data were assessed using paired t-test, repeated 
measures and Fisher’s exact test. The significance level 
for all tests was P=0.05.
Results
After 1 week of initiating the diet, 11 patients (16%) 
discontinued it because of its bad taste and recurrent 
vomiting. After 3 months, 2 cases could not keep 
the diet because of severe gastroenteritis and upper 
respiratory tract infections; therefore, 80% of the 
patients remained on the diet after 3 months. The mean 
age of the children (male: 52.7%, female: 47.3%, mean 
BMI: 14.9 kg/m²) was 3.6±1.9 years (1.5-11 years). The 
mean frequency of the seizures before intervention was 
22.6 seizures/day, but diminished to 9.7 seizures/day 
one week after the treatment, 6.4 seizures/day after one 
month, and was finally reported to be 8.9 seizures/day 
after three months. These frequencies were significantly 
various throughout the study (P < 0.05) (Table 1).
There was a 59% reduction in mean seizure frequency 
after one week, 75.3% after one month, and 63.5% 
after three months. On the other hand, efficacy (>50% 
reduction in seizure frequency) was observed in 61%, 
76% and 59% of the cases after 1 week, one month, and 
three months, respectively. Response to the diet was 
categorized as group 1 (becoming seizure-free), group 
2 (75%-99% reduction in the number of seizures/day), 
group 3 (50%-75% decrease), group 4 (25%-49% 
decrease) and group 5 (less than 25% reduction in the 
number of seizures/day, meaning no improvement). 
Efficacy was defined as a reduction of more than fifty 
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percent in seizure frequency. The overall effectiveness 
of the diet at 1 week was as following: three patients 
(4.5%) in group 1, 9 patients (13.6%) in group 2, and 30 
(45%) in group 3. Efficacy after 1 month was reported 
as 12 (18%) in group 1, 24 (36.4%) in group 2, and 14 
(21.2%) in group 3. After 3 months, 18.2%, 34.8% and 
6.1% were in group 1, 2 and 3, respectively (Figures 
1-2).
Neither the patients’ sex and age nor their parents’ 
occupation and educational level were related to the 
success rate of the ketogenic diet in the three follow-up 
visits (P> 0.05). The success rate of KD was related 
to the type of seizure in the first follow-up (P< 0.05) 
and the highest success rate was seen in the generalized 
type. But neither the epileptic syndrome nor the type 
of epilepsy was related to success rate of the ketogenic 
diet in the three follow-up visits (P > 0.05). We found 
a significant relationship between the type of epilepsy 
and response to the diet (P<0.017).
Psychomotor delay, CT scan and EEG findings had no 
association with the success rate of the ketogenic diet 
in on the first follow-ups (P > 0.05).
MRI and SPECT findings had no association with the 
success rate of ketogenic diet in none of the follow-ups 
(P >0.05). The number of the administered drugs, Ca/Cr 
ratio, and also imaging findings had no association with 
the success rate of the ketogenic diet in the three follow-
ups (P > 0.05). BMI had significant changes across the 
study which was interrelated with the success rate of 
ketogenic diet in all follow-ups (P < 0.05) (Table 2).
Discussion
The results of this analysis suggested that more than 
half of the children with refractory epilepsy had a 
clinically significant improvement after treatment with 
the ketogenic diet. Because these results are based 
on uncontrolled studies, it is possible to attribute the 
findings to the placebo effect, spontaneous remission, 
and/or random variation. However, it is unlikely that 
these factors account for the degree of seizure reduction 
seen in this trial. There is no reliable evidence from 
randomized controlled trials to support the use of the 
ketogenic diet for children with epilepsy. There are a 
number of larger observational studies for ketogenic 
diets, five of which are prospective. All authors 
comment on its efficacy in a significant proportion 
with recognized short-term side effects, but long-term 
effects have not yet been addressed.
Freeman et al., from Johns Hopkins University, reported 
the outcome of 150 consecutive children 3, 6, and 12 
months after initiating the diet (13), as well as their 
3- to 6-year follow-up (14). With an intention to treat 
methodology, these 150 children (who had an average of 
410 seizures per month and whose seizures had failed to 
adequately improve on a mean of 6.2 medications) had a 
dramatic outcome. They categorized seizure frequency 
reduction into four groups. Three months after the diet, 
they reported that 3% of the children were seizure free, 
31% (46 cases) of the children had a 90-99% reduction 
in seizures, 26% (39 cases) had a 50-89% reduction, 
and 24% (36 cases) had a less than 50% reduction in 
their seizures. Twelve months after initiating the diet, 
7% of the children were seizure-free, and another 20% 
had a 90% decrease in the frequency of the seizures. 
Three to 6 years later, 27% of the same children had few 
or no seizures. Most of them were now off the diet and 
on fewer or even no medications. In comparison, we 
evaluated 66 children with an average of 670 seizures 
per month who were taking 3-4 AEDs, and collected 
data one week, one month and 3 months after the diet. 
On the other hand, we categorized the response of the 
patients to diet as seizure free, 75%-99% reduction, 
50-74% reduction, 25-49% reduction and lower than 
25% reduction in seizures, as demonstrated in Figs. 1-2 
based on the duration of the diet, respectively.
Eileen Vining (15) evaluated 51 children, aged between 
1 and 8 years, that had 230 episodes of seizures per 
month and did not respond to 2 AEDs for 24 months. 
These children were followed for 12 months. Of 
these 51 cases, 88% continued the diet after 3 months 
whereas in our research, 13 cases could not continue 
the diet after this period of time. After 3 months, 88% of 
their patients remained on the diet and six cases (12%) 
were seizure free, 13 (25%) experienced a reduction of 
more than 90%, 15 (29%) had a 50-90% decrease, and 
54% of the patients showed a reduction of 50% or less 
in seizure frequency. In our study,  however, patients 
who did not respond (or were resistant) to 3-4 AEDs 
were enrolled and 80% remained on the diet. Bad 
taste of the diet was the main reason why they could 
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not keep the diet. Two of patients of Eileen Vining 
study, discontinued the diet because of intractable 
vomiting, gastroenteritis and upper respiratory tract 
infection (URI), and the authors did not include these 
two individuals in the failure group. In our study, after 
3 months, reduction in seizure frequency was better 
(18.2% were seizure-free, 59.1% had a higher than 
50% seizure reduction) than Vining’s study. After 12 
months, only 47% of their patients remained on the 
diet and 10% were seizure-free while in our study, 
34% (23 cases) continued the diet and 12 cases (19%) 
were seizure-free for a minimum of nine months.
Similar to our study, there was no relationship between 
seizure reduction due to ketogenic diet and age, sex, 
type of seizure, EEG findings and neuroimaging. Since 
the 1920s, reports of efficacy have been remarkably 
consistent across all age groups, seizure frequencies, 
and international locations (16-19). In general, 10%-
15% of the children who initiated the diet were seizure-
free after 1 year, 30% had a 90% reduction in seizures, 
and 40% to 50% found that the diet was either too 
difficult to continue or insufficiently effective and 
therefore discontinued it during the first 6 months. 
KD is more effective compared to the wide range of 
anticonvulsant drugs available, even in children with 
refractory seizures who take newer medications. 
Several recent meta-analyses have evaluated literatures 
regarding the diet and a vast amount of prospective 
uncontrolled and retrospective evidence has been 
found despite the lack of prospective controlled studies. 
Dissimilarity in culture, religion and financial status has 
caused KD differences, such as less or no fasting, using 
different ratios (more rice and less fat in some Eastern 
countries) and increased fluid and calorie ingestion 
(20). Comparing the costs of KD with anticonvulsant 
medications shows the benefits of this diet over other 
treatment modalities.
According to the above-mentioned facts, a major problem 
we faced during the research was discontinuation of the 
diet in 11 patients (11/66 or16.7%) in the first week 
and 13 patients after 3 months of implementing the 
diet; this dropout rate is almost similar to other studies 
using the traditional KD. Vining had a 20% dropout 
rate in his pediatric patients (15). In Freeman’s study, 
67 out of 150 children with refractory epilepsy (44.7%) 
discontinued the traditional KD within 1 year of 
initiation (13) and 23 of the 67 families discontinued 
the diet before 3 months. Thirty three out of 67 patients 
who discontinued the diet had a feeling that the diet 
was ineffective and 19 found it too restrictive, 13 
stopped the diet because of illness and 2 discontinued 
it for other reasons. Fortunately, Analysis of the causes 
of diet withdrawal by parents in our research showed 
that they mostly found it impractical and some of them 
complained of minor side effects in their children, like 
vomiting and behavioral changes (Table 3).
Side effects were also noticed in our patients during 
the 3-month follow-up, but longer follow-ups are 
required for observing potential late side effects of 
the KD. Investigators have classified complications as 
either early or late onset, depending on whether they 
are reported within 4 weeks of introducing the KD until 
stabilization, or thereafter. Acidosis, hypoglycemia, 
gastrointestinal distress, dehydration and lethargy are 
some of the unfavorable early-onset side effects of 
the KD which can be easily managed if the patients 
are not in the fasting state; however, these undesirable 
effects are usually temporary. Dyslipidemia, kidney 
stones and slowing of growth are subsequent side 
effects. Cholesterol and lipids adversely affect the diet. 
The most extensive study on dyslipidemia due to the 
diet followed 141 children prospectively over 2 years 
(20), and showed a rise in atherogenic apoB-containing 
lipoproteins, very low-density lipoprotein and low-
density lipoprotein and a fall in the antiatherogenic 
high-density lipoprotein cholesterol but children who 
were on the KD for 6 years returned to normal lipid 
profile (21). In our research, there was a significant 
statistical relationship between KD and hyperlipidemia, 
both cholesterol and triglyceride, but when it occurred, 
adjustment of the diet ratio brought the lipid levels 
back to normal limits. We did not have to stop the 
diet because of lipid abnormalities in any children 
whose seizures were effectively controlled by the diet. 
However, triglyceride level rose to 4000mg/dl which 
returned to normal limits following treatment with 
Simvastatine. The long-term effects of these changes in 
lipid profile, if any, are unknown but it should be noted 
that most patients remain on the diet for only 2 years 
and then return to a diet with a normal fat amount.
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A combination of acidosis, urine acidification, 
hypercalciuria and hypocitraturia leads to occurrence 
of kidney stones in 5% of the children on the KD (22). 
Despite the fact that anticonvulsants such as topiramate 
and zonisamide have carbonic anhydrase-inhibition 
properties and cause stone formation, using these drugs 
together with the diet did not increase the prevalence 
compared to either therapy (23). The prophylactic 
use of oral potassium citrate (Polycitra K) for urine 
alkalinization significantly decreases the risk of stones 
(24). We followed our cases for nephrolithiasis by 
assessing the urine calcium/creatinine ratio with a 
value higher than 0.2 being considered pathologic. 
Pathologic values were detected in 18 (27%) of the 
children. Two of these children had evidence of renal 
stones in ultrasonography so they were referred to a 
child nephrologist and were treated with polycitra 
and more water drinking. Consequently, the renal 
stones disappeared and the diet continued. Children 
on the diet grow normally, but the growth rate of the 
younger children seems to be slowed down more than 
that of the older children (25). Those on the diet for 
6 years are typically in the 10th percentile for height 
and weight (21). Growth seems to increase rapidly 
after diet discontinuation (26). Children on the KD 
were monitored carefully and regularly by a registered 
dietitian for weight and height which showed a 
significant reduction in weight after 3 months. 
Therefore, weight reduction had a statistical value after 
our follow-up (Table 2).
Bone density may be decreased after implementing 
the KD. A higher risk for skeletal fractures has been 
reported in children on the KD (21,27-29). Prevention 
with calcium supplementation, pamidronate, or lower 
KD ratios remains unproven.
In a recently published study focusing on tolerability 
and complications of the ketogenic diet, Kang and 
coworkers prospectively followed up a cohort of 129 
children treated with the ketogenic diet for a mean 
duration of 1 year
Although the number of our cases was limited to reach 
a definite conclusion, we did not find any relationship 
between the rate of the decrease in seizure frequency 
with the age of starting ketogenic diet, epileptic 
syndrome, brain imaging findings, EEG abnormalities, 
urinary ketone levels, and type of seizure. No such 
relationship has been found in other studies using 
the ketogenic diet (10-20), but some authors believe 
that certain epilepsy syndromes may be particularly 
well-treated by the traditional KD, including infantile 
spasms, Dravet syndrome, tuberous sclerosis complex 
and myoclonicastatic epilepsy (Doose syndrome) (30). 
In our research, we found a significant relationship 
between the type of epilepsy and the outcome of the 
diet (Table 3).
All our patients had 2+-3+ ketonuria after starting the 
diet. Because urine ketones were not checked daily 
during the research, ketosis could have occurred even 
sooner. There was no correlation between urinary 
ketone levels and seizure reduction, similar to a study 
conducted by Kossof (10).
Our study had several limitations including the 
dropouts, lack of assessing lipid profile, not ruling out 
metabolic diseases and not evaluating hypercalciuria 
before starting the diet, the short follow-up period (that 
should be extended to a minimum of 6 months) and the 
small number of the sample size.
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Fig 1. Percentage of decreased frequency of seizures 1 week, 1 month and 3 months after
starting the diet 





































Fig.2. The number/percent of seizure-free cases and cases 
with seizure while on ketogenic diet after 1 week, 1 month and 3 months
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